Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Endometriosis recurrence after conservative surgery is not infrequent. Variable regimens of hormonal therapy have been proposed as adjuvant post-operative measures for prophylaxis against recurrence. Among these, the combined oral contraceptive pills (OCP), represents a valuable option in terms of safety and tolerability for long-term use. The objective of this review is to evaluate the effect of post-operative use of OCP in preventing symptom recurrence, and/or anatomical relapse of endometriosis. METHODS: A systematic search of Medline identified seven studies evaluating post-operative OCP treatment on prevention of endometriosis recurrence. RESULTS: A reduction in anatomical relapse rate was observed when oral contraceptive therapy was administered for more than 1 year after conservative surgery. Post-operative use of OCP was associated with a reduction in frequency and intensity of dysmenorrhoea recurrence. No association was found between OCP therapy and dyspareunia prevention, although the effect of OCP on chronic pelvic pain was conflicting. CONCLUSION: Long-term OCP therapy can be a reliable adjuvant post-operative measure to prevent or reduce frequency/severity of recurrent dysmenorrhoea and anatomical relapse of endometriosis. Since both continuous and cyclic OCP administration regimens seem to have comparable effects, the choice of regimen can be modulated according to patient preferences. The protective effect seems to be related to the duration of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some studies showed that COCs prevent and reduce frequency and severity of recurrent dysmenorrhea and relapse of endometriosis after surgery [252–256].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [252]
In the citing paper
“Clinicians should consider prescribing the postoperative use of a LNG-IUS system (52 mg) or a combined hormonal contraceptive for at least 18–24 months for the secondary prevention of endometriosis-associated dysmenorrhoea (Seracchioli et al., 2009; Lee et al., 2018; Song et al., 2018; Chen et al., 2020; Zakhari et al., 2021).”
From ESHRE guideline: endometriosis (2022) · cites this paper as Seracchioli et al., 2009
In the citing paper
“As endometriomas appear to develop from ovarian follicles and corpora lutea (Vercellini et al., 2009b), inhibition of ovulation with oral contraceptives (OCs) or progestins should decrease the risk of cyst recurrence (Seracchioli et al., 2009).”
From When more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement (2019) · cites this paper as Seracchioli et al., 2009
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Visual analogue scales: measurement of subjective phenomena.
Gift, A. G. (1989) · PubMed · Cited by 1,138
Immune and inflammatory mechanisms in neuropathic pain
Moalem, G., & Tracey, D. J. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.004 · Cited by 774
Recurrence of endometriosis and its control
Guo, S.-W. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp007 · Cited by 719
Pain Measurement and Assessment
Melzack, R. (1983) · Medical Entomology and Zoology · Cited by 585
Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications
Fauconnier, A., & Chapron, C. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi029 · Cited by 522
Laparoscopic excision of endometriosis: A randomized, placebo-controlled trial
Abbott, J., Hawe, J., Hunter, D., Holmes, M., Finn, P., & Garry, R. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.046 · Cited by 502
The impact of endometriosis upon quality of life: a qualitative analysis
Jones, G., Jenkinson, C., & Kennedy, S. (2004) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/01674820400002279 · Cited by 291
Vercellini, P., Frontino, G., De Giorgi, O., Pietropaolo, G., Pasin, R., & Crosignani, P. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00794-5 · Cited by 289
Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis
Anaf, V., Chapron, C., El Nakadi, I., De Moor, V., Simonart, T., & Noël, J.-C. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.057 · Cited by 258
Research works printed but not linked: 1
- 2006, Brain research. Brain research reviews, 5, 240
Cited by
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
“In women operated on for endometriosis, clinicians are recommended to prescribe post-operative use of a LNG-IUS or a combined hormonal contraceptive for at least 18–24 months, as one of the options for the secondary prevention of endometriosis-associated dysmenorrhoea, but not for non-menstrual pelvic pain or dyspareu…”
BackgroundEndometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
ESHRE guideline: endometriosis
Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac009 · Cited by 1,712
“…the postoperative use of a LNG-IUS system (52mg) or a combined hormonal contraceptive for at least 18–24months for the secondary prevention of endometriosis-associated dysmenorrhoea (Seracchioli et al. , 2009; Lee et al. , 2018; Song et al. , 2018; Chen et al. , 2020; Zakhari et al. , 2021).”
Self-citationDeep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management
Abrao, M. S., Petraglia, F., Falcone, T., Keckstein, J., Osuga, Y., & Chapron, C. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv003 · Cited by 398
“, 2010) and pelvic pain (Seracchioli et al., 2009).”
BackgroundMethodTreatment of pelvic pain associated with endometriosis: a committee opinion
(2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.012 · Cited by 397
Metadata
- Authors
- Seracchioli, R., Mabrouk, M., Manuzzi, L., Vicenzi, C., Frasca, C., Elmakky, A., & Venturoli, S.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-22
- Volume
- 24
- Issue
- 11
- Pages
- 2729-2735
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2109848598
- Cited by
- 158
- References
- 34
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 22 · 2021: 8 · 2020: 9 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 6 · 2015: 14 · 2014: 15 · 2013: 13 · 2012: 14
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- endometriosis, endometriosis recurrence, combined oral contraceptives, conservative surgery, adjuvant endocrine therapy, dysmenorrhea, dyspareunia, chronic pelvic pain, treatment duration
- MeSH terms
- Clinical Trials as Topic, Contraceptives, Oral, Hormonal, Endometriosis, Female, Humans, Postoperative Period, Retrospective Studies, Randomized Controlled Trials as Topic, Treatment Outcome, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis. https://app.cochat.ai/papers/10.1093/humrep/dep259
- The paper
- Seracchioli, R., Mabrouk, M., Manuzzi, L., Vicenzi, C., Frasca, C., Elmakky, A., & Venturoli, S. (2009). Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis. Human Reproduction. https://doi.org/10.1093/humrep/dep259
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.